Takeda Pharmaceutical (Germany) Analysis
| TKD Stock | EUR 25.17 0.05 0.20% |
Takeda Pharmaceutical is fairly valued with Real Value of 25.53 and Hype Value of 25.17. The main objective of Takeda Pharmaceutical stock analysis is to determine its intrinsic value, which is an estimate of what Takeda Pharmaceutical is worth, separate from its market price. There are two main types of Takeda Pharmaceutical's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Takeda Pharmaceutical's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Takeda Pharmaceutical's stock to identify patterns and trends that may indicate its future price movements.
The Takeda Pharmaceutical stock is traded in Germany on Frankfurt Exchange, with the market opening at 08:00:00 and closing at 22:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Germany. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Takeda Pharmaceutical's ongoing operational relationships across important fundamental and technical indicators.
Takeda |
Takeda Stock Analysis Notes
About 41.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.95. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Takeda Pharmaceutical has Price/Earnings To Growth (PEG) ratio of 0.58. The entity last dividend was issued on the 31st of March 2026. Takeda Pharmaceutical Company Limited, together with its subsidiaries, engages in the research, development, manufacturing, and marketing of pharmaceutical products, over-the-counter medicines and quasi-drug consumer products, and other healthcare products. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Tokyo, Japan. Takeda Pharmaceutical operates under Drug Manufacturers - Specialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 49578 people. To find out more about Takeda Pharmaceutical contact Christophe Weber at 81 3 3278 2111 or learn more at https://www.takeda.com.Takeda Pharmaceutical Investment Alerts
| Takeda Pharmaceutical generated a negative expected return over the last 90 days | |
| Takeda Pharmaceutical has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations |
Takeda Market Capitalization
The company currently falls under 'Large-Cap' category with a current market capitalization of 44.8 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Takeda Pharmaceutical's market, we take the total number of its shares issued and multiply it by Takeda Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Takeda Profitablity
Takeda Pharmaceutical's profitability indicators refer to fundamental financial ratios that showcase Takeda Pharmaceutical's ability to generate income relative to its revenue or operating costs. If, let's say, Takeda Pharmaceutical is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Takeda Pharmaceutical's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Takeda Pharmaceutical's profitability requires more research than a typical breakdown of Takeda Pharmaceutical's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.07 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.13 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.13. Technical Drivers
As of the 24th of November, Takeda Pharmaceutical has the Risk Adjusted Performance of (0.06), variance of 1.1, and Coefficient Of Variation of (1,202). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Takeda Pharmaceutical, as well as the relationship between them. Please validate Takeda Pharmaceutical value at risk, skewness, and the relationship between the maximum drawdown and potential upside to decide if Takeda Pharmaceutical is priced more or less accurately, providing market reflects its prevalent price of 25.17 per share.Takeda Pharmaceutical Price Movement Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Takeda Pharmaceutical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Takeda Pharmaceutical. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Takeda Pharmaceutical Outstanding Bonds
Takeda Pharmaceutical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Takeda Pharmaceutical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Takeda bonds can be classified according to their maturity, which is the date when Takeda Pharmaceutical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Takeda Pharmaceutical Predictive Daily Indicators
Takeda Pharmaceutical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Takeda Pharmaceutical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Takeda Pharmaceutical Forecast Models
Takeda Pharmaceutical's time-series forecasting models are one of many Takeda Pharmaceutical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Takeda Pharmaceutical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Takeda Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Takeda Pharmaceutical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Takeda shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Takeda Pharmaceutical. By using and applying Takeda Stock analysis, traders can create a robust methodology for identifying Takeda entry and exit points for their positions.
Takeda Pharmaceutical Company Limited, together with its subsidiaries, engages in the research, development, manufacturing, and marketing of pharmaceutical products, over-the-counter medicines and quasi-drug consumer products, and other healthcare products. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Tokyo, Japan. Takeda Pharmaceutical operates under Drug Manufacturers - Specialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 49578 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Takeda Pharmaceutical to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Money Managers Now
Money ManagersScreen money managers from public funds and ETFs managed around the world |
| All Next | Launch Module |
Complementary Tools for Takeda Stock analysis
When running Takeda Pharmaceutical's price analysis, check to measure Takeda Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Takeda Pharmaceutical is operating at the current time. Most of Takeda Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Takeda Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Takeda Pharmaceutical's price. Additionally, you may evaluate how the addition of Takeda Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |